SCHEMBL25005767

SCHEMBL25005767

N#Cc1ccc2cc(-c3ccc4c5c(-c6ccccc6)c6c(cc7c8ccccc8c8cccc6c87)c(-c6ccccc6)c5c5cccc3c54)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 2/20 0.38
▸ CYP11B2 P19099 2/20 0.38
▸ CYP17A1 P05093 1/20 0.38
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ MEN1 O00255 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ ALDH1A1 P00352 5/20 0.34
▸ CYP1A2 P05177 4/20 0.34
▸ CYP3A4 P08684 3/20 0.34
▸ CYP2C19 P33261 3/20 0.34
▸ CLK4 Q9HAZ1 3/20 0.34
▸ LMNA P02545 3/20 0.34
▸ HSD17B10 Q99714 3/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ CYP19A1 P11511 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ XDH P47989 1/20 0.33
▸ SLC22A12 Q96S37 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22916738 1.00 CYP11B1 (0.38) CYP11B1CYP11B2CYP17A1CA1CA2
SCHEMBL20802905 0.94 CYP17A1 (0.35) CYP11B1CYP11B2CYP17A1ALDH1A1CYP1A2
SCHEMBL20802973 0.94 CYP17A1 (0.35) CYP11B1CYP11B2CYP17A1ALDH1A1CYP1A2
SCHEMBL20803114 0.94 CYP17A1 (0.35) CYP11B1CYP11B2CYP17A1ALDH1A1CYP1A2
SCHEMBL23349018 0.92 KDM1A (0.37) CYP11B1CYP11B2CYP17A1CA1CA2
SCHEMBL23349048 0.92 KDM1A (0.37) CYP11B1CYP11B2CYP17A1CA1CA2
SCHEMBL14139947 0.90 ALDH1A1 (0.38) MEN1KMT2AALDH1A1CYP1A2CYP3A4
SCHEMBL14139948 0.90 ALDH1A1 (0.38) MEN1KMT2AALDH1A1CYP1A2CYP3A4
SCHEMBL14139970 0.89 PRKDC (0.35) MEN1KMT2AALDH1A1FASNPGR
SCHEMBL14139961 0.89 PRKDC (0.35) MEN1KMT2AALDH1A1FASNPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230345816-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-26 — — US disclosed
US-20230345816-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-26 — — US disclosed
US-20230242465-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-08-03 — — US disclosed
US-20230242465-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-08-03 — — US disclosed
US-20230047477-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 — — US disclosed
US-20230042023-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242465-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EP300, RPS19, RER1 CYP11B1 3341/4885CYP11B2 3406/4885CYP17A1 3314/4885
US-20230345816-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, YBX1 CYP11B1 1494/4885CYP11B2 1221/4885CYP17A1 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback